JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB28311

Anti-Angiotensin Converting Enzyme 1 antibody

5

(2 Reviews)

|

(12 Publications)

Rabbit Polyclonal Angiotensin Converting Enzyme 1 antibody. Suitable for WB, IHC-P and reacts with Human, Recombinant fragment samples. Cited in 12 publications. Immunogen corresponding to Synthetic Peptide within Human ACE.

View Alternative Names

CD143, DCP, DCP1, ACE, Angiotensin-converting enzyme, Dipeptidyl carboxypeptidase I, Kininase II

1 Images
Western blot - Anti-Angiotensin Converting Enzyme 1 antibody (AB28311)
  • WB

Unknown

Western blot - Anti-Angiotensin Converting Enzyme 1 antibody (AB28311)

Lane 1:

Molecular weight markers

Lanes 2 - 4:

Western blot - Anti-Angiotensin Converting Enzyme 1 antibody (ab28311) at 1/1000 dilution

Lane 2:

rh-ACE-1 at 0.05 µg

Lane 3:

rh-ACE-1 at 0.01 µg

Lane 4:

rh-ACE-1 at 0.001 µg

Predicted band size: 150 kDa

Observed band size: 150 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

Synthetic Peptide within Human ACE. The exact immunogen used to generate this antibody is proprietary information.

P12821

Specificity

ab28311 recognizes metallopeptidase ACE1.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p>when using colorimetric substrates such as BCIP/NBT and 1/5000 for chemiluminescent substrates. Predicted molecular weight: 150 kDa. Dilution optimised using Chromogenic detection</p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" }, "Recombinant fragment": { "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody has been peptide-affinity purified and concentrated.
Storage buffer
Preservative: 0.05% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Angiotensin Converting Enzyme 1 also known as ACE1 or ACE is an important enzyme in the renin-angiotensin system. This enzyme exhibits a significant role in blood pressure regulation. ACE1 is a zinc-metallopeptidase with a molecular weight of approximately 130 kDa. It converts angiotensin I into the potent vasoconstrictor angiotensin II a critical function in cardiovascular physiology. ACE1 is widely expressed in endothelial cells particularly in the lungs kidneys and the small intestine.
Biological function summary

The enzyme generates angiotensin II by cleaving angiotensin I. Angiotensin II an important effector peptide impacts cardiovascular and renal systems influencing vasoconstriction and fluid balance. While not directly forming a complex ACE1's activity increases the potency of angiotensin II which binds to angiotensin II receptors to exert its effects therefore indirectly forming a functional signaling complex.

Pathways

ACE1 plays a central role in the renin-angiotensin system and the kallikrein-kinin system. The enzyme's activity boosts angiotensin II production which connects it to the regulation of blood pressure via the renin-angiotensin pathway. ACE1 also indirectly interacts with proteins like bradykinin by degrading them modulating kinin-related functions and influencing inflammation and tension in vascular smooth muscle.

Understanding ACE1 is important for addressing hypertension and congestive heart failure. ACE1's conversion of angiotensin I to angiotensin II means overactivity can cause elevated blood pressure leading to hypertension. This makes ACE inhibitors such as lisinopril and ramipril therapeutic for these conditions. Furthermore its connection with aldosterone production places ACE1 in relevance to heart failure as excessive aldosterone can cause detrimental remodeling of cardiac tissue.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of a variety of circulating hormones, such as angiotensin I, bradykinin or enkephalins, thereby playing a key role in the regulation of blood pressure, electrolyte homeostasis or synaptic plasticity (PubMed : 15615692, PubMed : 20826823, PubMed : 2558109, PubMed : 4322742, PubMed : 7523412, PubMed : 7683654). Composed of two similar catalytic domains, each possessing a functional active site, with different selectivity for substrates (PubMed : 10913258, PubMed : 1320019, PubMed : 1851160, PubMed : 19773553, PubMed : 7683654, PubMed : 7876104). Plays a major role in the angiotensin-renin system that regulates blood pressure and sodium retention by the kidney by converting angiotensin I to angiotensin II, resulting in an increase of the vasoconstrictor activity of angiotensin (PubMed : 11432860, PubMed : 1851160, PubMed : 19773553, PubMed : 23056909, PubMed : 4322742). Also able to inactivate bradykinin, a potent vasodilator, and therefore enhance the blood pressure response (PubMed : 15615692, PubMed : 2558109, PubMed : 4322742, PubMed : 6055465, PubMed : 6270633, PubMed : 7683654). Acts as a regulator of synaptic transmission by mediating cleavage of neuropeptide hormones, such as substance P, neurotensin or enkephalins (PubMed : 15615692, PubMed : 6208535, PubMed : 6270633, PubMed : 656131). Catalyzes degradation of different enkephalin neuropeptides (Met-enkephalin, Leu-enkephalin, Met-enkephalin-Arg-Phe and possibly Met-enkephalin-Arg-Gly-Leu) (PubMed : 2982830, PubMed : 6270633, PubMed : 656131). Acts as a regulator of synaptic plasticity in the nucleus accumbens of the brain by mediating cleavage of Met-enkephalin-Arg-Phe, a strong ligand of Mu-type opioid receptor OPRM1, into Met-enkephalin (By similarity). Met-enkephalin-Arg-Phe cleavage by ACE decreases activation of OPRM1, leading to long-term synaptic potentiation of glutamate release (By similarity). Also acts as a regulator of hematopoietic stem cell differentiation by mediating degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) (PubMed : 26403559, PubMed : 7876104, PubMed : 8257427, PubMed : 8609242). Acts as a regulator of cannabinoid signaling pathway by mediating degradation of hemopressin, an antagonist peptide of the cannabinoid receptor CNR1 (PubMed : 18077343). Involved in amyloid-beta metabolism by catalyzing degradation of Amyloid-beta protein 40 and Amyloid-beta protein 42 peptides, thereby preventing plaque formation (PubMed : 11604391, PubMed : 16154999, PubMed : 19773553). Catalyzes cleavage of cholecystokinin (maturation of Cholecystokinin-8 and Cholecystokinin-5) and Gonadoliberin-1 (both maturation and degradation) hormones (PubMed : 10336644, PubMed : 2983326, PubMed : 7683654, PubMed : 9371719). Degradation of hemoregulatory peptide N-acetyl-SDKP (AcSDKP) and amyloid-beta proteins is mediated by the N-terminal catalytic domain, while angiotensin I and cholecystokinin cleavage is mediated by the C-terminal catalytic region (PubMed : 10336644, PubMed : 19773553, PubMed : 7876104).. Angiotensin-converting enzyme, soluble form. Soluble form that is released in blood plasma and other body fluids following proteolytic cleavage in the juxtamembrane stalk region.. Isoform Testis-specific. Isoform produced by alternative promoter usage that is specifically expressed in spermatocytes and adult testis, and which is required for male fertility (PubMed : 1651327, PubMed : 1668266). In contrast to somatic isoforms, only contains one catalytic domain (PubMed : 1651327, PubMed : 1668266). Acts as a dipeptidyl carboxypeptidase that removes dipeptides from the C-terminus of substrates (PubMed : 1668266, PubMed : 24297181). The identity of substrates that are needed for male fertility is unknown (By similarity). May also have a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. The GPIase activity was reported to be essential for the egg-binding ability of the sperm (By similarity). This activity is however unclear and has been challenged by other groups, suggesting that it may be indirect (By similarity).
See full target information ACE

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:1338 PubMed39915484

2025

Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes.

Applications

Unspecified application

Species

Unspecified reactive species

Rebecca Craig-Schapiro,Ge Li,Kevin Chen,Jesus M Gomez-Salinero,Ryan Nachman,Aleksandra Kopacz,Ryan Schreiner,Xiaojuan Chen,Qiao Zhou,Shahin Rafii,David Redmond

International journal of molecular sciences 24: PubMed37834402

2023

Transferrin-Conjugated Melittin-Loaded L-Arginine-Coated Iron Oxide Nanoparticles for Mitigating Beta-Amyloid Pathology of the 5XFAD Mouse Brain.

Applications

Unspecified application

Species

Unspecified reactive species

Moonseok Choi,Junghwa Ryu,Huy Duc Vu,Dongsoo Kim,Young-Jin Youn,Min Hui Park,Phuong Tu Huynh,Gyu-Bin Hwang,Sung Won Youn,Yun Ha Jeong

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 73: PubMed37087563

2023

Angiotensin-(1-7) can promote cell migration and tumor growth of clear cell renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

P Sobczuk,J Trzcinska-Danielewicz,L Koperski,A Girstun,A Cudnoch-Jedrzejewska

Translational research : the journal of laboratory and clinical medicine 257:43-53 PubMed36736951

2023

Topical captopril: a promising treatment for secondary lymphedema.

Applications

Unspecified application

Species

Unspecified reactive species

Stav Brown,Gabriela D G Nores,Ananta Sarker,Catherine Ly,Claire Li,Hyeung Ju Park,Geoffrey E Hespe,Jason Gardenier,Kevin Kuonqui,Adana Campbell,Jinyeon Shin,Raghu P Kataru,Omer Aras,Babak J Mehrara

Oxidative medicine and cellular longevity 2022:3698219 PubMed35222797

2022

Endothelial MicroRNA-483-3p Is Hypertension-Protective.

Applications

Unspecified application

Species

Unspecified reactive species

Fenqing Shang,Xuan Guo,Yueer Chen,Chen Wang,Jie Gao,Ergang Wen,Baochang Lai,Liang Bai

The Journal of international medical research 48:300060520943453 PubMed32790534

2020

Protective effects of irbesartan and benazepril against vaginal vascular remodeling and fibrosis in female spontaneously hypertensive rats.

Applications

Unspecified application

Species

Unspecified reactive species

Ruixin Ma,Yang Zhao,Xiaorong Yu,Ningyin Li,Qiongying Wang,Wei Liang,Xu Zhao,Jing Yu

British journal of pharmacology 177:3691-3711 PubMed32352559

2020

Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Applications

Unspecified application

Species

Unspecified reactive species

Swayam Prakash Srivastava,Julie E Goodwin,Keizo Kanasaki,Daisuke Koya

Hypertension research : official journal of the Ja 42:1507-1517 PubMed31138899

2019

Azilsartan causes natriuresis due to its sympatholytic action in kidney disease.

Applications

Unspecified application

Species

Unspecified reactive species

Satoshi Kidoguchi,Naoki Sugano,Koki Takane,Yasuhito Takahashi,Norihiko Morisawa,Miki Yarita,Naomi Hayashi-Ishikawa,Goro Tokudome,Takashi Yokoo

Journal of cellular physiology 234:20420-20431 PubMed30989646

2019

Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Shrinidh Joshi,Hannah Wollenzien,Estelle Leclerc,Yagna Pr Jarajapu

Frontiers in physiology 9:1370 PubMed30364113

2018

Comparative Expression of Renin-Angiotensin Pathway Proteins in Visceral Versus Subcutaneous Fat.

Applications

Unspecified application

Species

Unspecified reactive species

Yuebo Zhang,Kiran R Somers,Christiane Becari,Katarzyna Polonis,Michaela A Pfeifer,Alina M Allen,Todd A Kellogg,Naima Covassin,Prachi Singh
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com